Physician profile
Andrew E Foderaro
NPI 1700179942
$6,583.53
in general payments reported to CMS, 2019-2025
6 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2021: $911 · 2022: $4,452 · 2023: $856 · 2024: $153 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $750 · Food and Beverage: $346 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $750.00 |
| Food and Beverage | $345.67 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,440.55 | 2021-2023 | Da Vinci Surgical System |
| Ethicon INC. | $755.55 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $147.92 | 2021-2024 | Fasenra |
| Medtronic, INC. | $105.71 | 2025 | Signia |
| Regeneron Healthcare Solutions, INC. | $105.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.24 | 2024 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Foderaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.